0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Over-the-Counter Pain Medication - Global Strategic Business Report

  • PDF Icon

    Report

  • 483 Pages
  • June 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6087491
The global market for Over-the-Counter Pain Medication was valued at US$26.3 Billion in 2024 and is projected to reach US$30.9 Billion by 2030, growing at a CAGR of 2.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Over-the-Counter Pain Medication market.

Global Over-the-Counter Pain Medication Market - Key Trends & Drivers Summarized

Why Are Over-the-Counter Pain Medications the First Line of Treatment for Millions Worldwide?

Over-the-counter (OTC) pain medications play an indispensable role in modern healthcare by providing easily accessible, fast-acting relief for common conditions such as headaches, muscle pain, backaches, menstrual cramps, arthritis, and minor injuries. These medications - chiefly acetaminophen (paracetamol), ibuprofen, naproxen, and aspirin - are often the first point of intervention before formal medical consultation. Their widespread availability without a prescription, broad therapeutic range, and strong safety profile (when used appropriately) have made them a cornerstone of consumer self-care worldwide.

The rising prevalence of chronic pain conditions, sedentary lifestyles, and aging populations has reinforced demand for OTC analgesics. Increasing health literacy, along with digital health platforms and pharmacist-guided self-medication, has empowered consumers to manage mild-to-moderate pain independently. Moreover, public health efforts to limit unnecessary opioid use have positioned OTC pain relievers as a safer alternative for non-severe pain. Their low cost, brand familiarity, and rapid onset of action have ensured that these drugs remain embedded in daily health routines across geographies and demographics.

How Are Formulation Innovations and Combination Therapies Expanding the Utility of OTC Analgesics?

Product innovation in the OTC pain relief market is focusing on enhanced delivery mechanisms, multi-symptom formulations, and consumer convenience. Liquid gels, effervescent tablets, soft chews, transdermal patches, and topical gels are being developed to improve absorption rates and target specific pain types. Dual-ingredient products combining acetaminophen with caffeine or ibuprofen with antacids are expanding functionality for headaches, migraines, and gastrointestinal comfort. Additionally, 12-hour or extended-release tablets are being introduced to provide prolonged relief with fewer doses.

Natural and herbal OTC pain relievers - incorporating turmeric, arnica, menthol, or cannabidiol (CBD) - are gaining popularity among consumers seeking alternative or adjunctive treatments. Pediatric and geriatric formulations now feature lower dosages, child-proof packaging, and flavor masking to improve adherence and safety. Digital integration, such as QR codes linking to dosage calculators and safety warnings, is also enhancing user education. These developments are not only meeting evolving consumer expectations but also driving product differentiation in an increasingly competitive landscape.

Which Demographics and Retail Ecosystems Are Propelling Growth in the OTC Pain Relief Market?

The broad utility of OTC analgesics spans virtually all age groups, but specific demographics are driving unique demand trends. Women frequently use OTC pain relievers for menstrual cramps, migraines, and musculoskeletal pain. Older adults rely on these medications for osteoarthritis, joint pain, and chronic inflammatory conditions, although dosage adjustment and GI safety remain concerns. Younger consumers, particularly those engaged in fitness and active lifestyles, use fast-acting pain relievers for sports injuries and recovery routines.

Retail pharmacies, supermarkets, and e-commerce platforms dominate distribution. Online channels, in particular, are growing rapidly due to subscription models, bulk discounts, and health-and-wellness bundles. Emerging markets in Asia, Latin America, and Africa are experiencing increased adoption through public health education campaigns, expanded retail infrastructure, and growing middle-class income. North America and Europe continue to lead in innovation and regulatory compliance, while Asia-Pacific represents the fastest-growing region in terms of unit volumes and brand proliferation.

What Is Driving Long-Term Growth and Competitive Innovation in the OTC Pain Medication Market?

The growth in the OTC pain medication market is driven by chronic pain prevalence, self-care trends, and healthcare cost containment strategies. As healthcare systems globally prioritize preventive care and decongestion of clinical pathways, OTC medications offer a low-risk, cost-effective solution for non-emergency pain management. Increased regulatory support for pharmacist-prescribed or guided OTC use is expanding accessibility and responsible usage.

Market leaders are investing in brand equity, active ingredient optimization, and strategic acquisitions to diversify their portfolios. Collaborations with telehealth platforms, mobile health apps, and wearables are opening new channels for pain monitoring and OTC product recommendation. Sustainability in packaging, inclusion of clean-label ingredients, and social media marketing campaigns are further resonating with eco-conscious and digitally engaged consumers. As pain relief continues to be a high-frequency use case in self-medication, the OTC market is set to remain a resilient, innovation-driven, and consumer-aligned healthcare segment.

Report Scope

The report analyzes the Over-the-Counter Pain Medication market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments: Drug Class (Non-steroidal Anti-inflammatory Drugs, Local Anesthetics, Acetaminophen, Salicylates, Other Drug Classes); Administration Route (Oral, Topical, Other Administration Routes); Dosage Form (Tablets / Capsules, Liquids, Creams, Gels, Other Dosage Forms); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies).

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Non-steroidal Anti-inflammatory Drugs segment, which is expected to reach US$12.1 Billion by 2030 with a CAGR of a 2.1%. The Local Anesthetics segment is also set to grow at 2.7% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $7.2 Billion in 2024, and China, forecasted to grow at an impressive 5.0% CAGR to reach $5.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Over-the-Counter Pain Medication Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Over-the-Counter Pain Medication Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Over-the-Counter Pain Medication Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Laboratories, Alkem Laboratories Ltd., Bayer AG, Boehringer Ingelheim GmbH, Cipla Ltd. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 42 companies featured in this Over-the-Counter Pain Medication market report include:

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc
  • Haleon plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What's Included in This Edition:

  • Tariff-adjusted market forecasts by region and segment
  • Analysis of cost and supply chain implications by sourcing and trade exposure
  • Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

  • Finalized tariff impacts and new trade agreement effects
  • Updated projections reflecting global sourcing and cost shifts
  • Expanded country-specific coverage across the industry

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 and a Looming Global Recession
  • Over-the-Counter Pain Medication - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Consumer Preference for Self-Care and Immediate Relief Propels Demand for OTC Pain Medications
  • Expansion of E-Pharmacy Platforms Strengthens Direct Access to Non-Prescription Analgesics
  • Increased Incidence of Musculoskeletal and Lifestyle-Induced Pain Drives Repeat Use of OTC Options
  • Availability of Combination Formulations With Multi-Symptom Relief Throws the Spotlight on Product Innovation
  • Regulatory Reclassification of Former Prescription Medications Spurs Market Expansion in OTC Channels
  • Emphasis on Label Transparency and Ingredient Clarity Enhances Consumer Confidence
  • Growing Aging Population and Arthritis Cases Propel Demand for Long-Term Pain Management Solutions
  • Launch of Extended-Release and Fast-Acting Pain Relievers Improves Patient Compliance
  • Widening Use of Topical and Patch-Based OTC Analgesics Expands Non-Oral Product Categories
  • Emergence of Pediatric and Teen-Specific Pain Relief Products Expands Demographic Reach
  • Rising Demand for Natural and Herbal OTC Alternatives Supports Clean Pain Management Trends
  • Increased Regulatory Monitoring on Opioid Use Reinforces Shift Toward Safer OTC Pain Relievers
  • Integration of QR Codes and Mobile Apps for Dosing Guidance Supports Responsible Self-Medication
  • Collaborations Between OTC Brands and Fitness Retailers Drive Cross-Selling Opportunities
  • Availability of Pain-Specific Supplements Enhances Competition for Traditional OTC Analgesics
  • Awareness Campaigns on Pain Type Differentiation Improve Targeted Product Positioning
  • Innovation in Dual-Action Pain Relief With Anti-Inflammatory and Muscle Relaxants Propels Market Differentiation
  • Challenges in Drug Interactions and Contraindications Highlight the Need for Pharmacist-Backed Education
  • Retail Store Loyalty Programs and Bundled Promotions Strengthen Consumer Retention in OTC Categories
  • Growing Use of OTC Analgesics in Minor Sports Injuries Supports Expansion in Youth and Active Lifestyles
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Over-the-Counter Pain Medication Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Over-the-Counter Pain Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 3: World Historic Review for Over-the-Counter Pain Medication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 4: World 15-Year Perspective for Over-the-Counter Pain Medication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Non-steroidal Anti-inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 6: World Historic Review for Non-steroidal Anti-inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 7: World 15-Year Perspective for Non-steroidal Anti-inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Local Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 9: World Historic Review for Local Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 10: World 15-Year Perspective for Local Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Acetaminophen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 12: World Historic Review for Acetaminophen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 13: World 15-Year Perspective for Acetaminophen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Salicylates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 15: World Historic Review for Salicylates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 16: World 15-Year Perspective for Salicylates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 18: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 19: World 15-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Liquids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 21: World Historic Review for Liquids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 22: World 15-Year Perspective for Liquids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Creams by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 24: World Historic Review for Creams by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 25: World 15-Year Perspective for Creams by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Gels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 27: World Historic Review for Gels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 28: World 15-Year Perspective for Gels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 29: World Recent Past, Current & Future Analysis for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 30: World Historic Review for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 31: World 15-Year Perspective for Other Dosage Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 32: World Recent Past, Current & Future Analysis for Tablets / Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 33: World Historic Review for Tablets / Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 34: World 15-Year Perspective for Tablets / Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 35: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 36: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 37: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 38: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 39: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 40: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 41: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 42: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 43: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 44: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 45: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 46: World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 47: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 48: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 49: World 15-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 50: World Recent Past, Current & Future Analysis for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 51: World Historic Review for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 52: World 15-Year Perspective for Other Administration Routes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Over-the-Counter Pain Medication Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • GlaxoSmithKline plc
  • Haleon plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Table Information

This website uses cookies to ensure you get the best experience. Learn more